AbbVie
ABBV
$167.80
Share price
-1.03%
Change (1 day)
2.27%
Change (1 year)
Categories
The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol “ABBV”.
Number of shares outstanding for AbbVie (ABBV)
Number of shares outstanding as of April 2024 : 1,765,940,733
According to AbbVie's latest financial reports and stock price the company's current number of shares outstanding is 1,765,940,733. At the end of 2023 the company had 1,765,940,733 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for AbbVie from 2011 to 2023
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2023 | 1.76 B | -0.18% |
| 2022 | 1.76 B | 0.05% |
| 2021 | 1.76 B | 0.18% |
| 2020 | 1.76 B | 19.35% |
| 2019 | 1.47 B | 0.01% |
| 2018 | 1.47 B | -7.12% |
| 2017 | 1.59 B | -0.02% |
| 2016 | 1.59 B | -1.08% |
| 2015 | 1.60 B | 1.16% |
| 2014 | 1.59 B | 0.25% |
| 2013 | 1.58 B | 0.47% |
| 2012 | 1.58 B | -2.23% |
| 2011 | 1.61 B |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | 5,647,000,000 | 219.77% | 🇺🇸 USA |
 Eli Lilly LLY | 949,379,000 | -46.24% | 🇺🇸 USA |
 Amgen AMGN | 535,000,000 | -69.70% | 🇺🇸 USA |
 Biogen BIIB | 144,800,000 | -91.80% | 🇺🇸 USA |
 Gilead Sciences GILD | 1,248,000,000 | -29.33% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 2,057,000,000 | 16.48% | 🇺🇸 USA |
 AstraZeneca AZN | 3,098,000,000 | 75.43% | 🇬🇧 UK |
 GlaxoSmithKline GSK | 2,028,000,000 | 14.84% | 🇬🇧 UK |
 Neurocrine Biosciences
NBIX | 97,900,000 | -94.46% | 🇺🇸 USA |